Steve Baughman and Megan Raymond Discuss Novo Nordisk’s PTAB Wins, Featured Among “The Biggest PTAB Developments in 2023,” with Law360
Partners Steven Baughman and Megan Raymond spoke to Law360 about the implications of their PTAB victories for pharmaceutical giant Novo Nordisk and PTAB practice in general. In “The Biggest PTAB Developments In 2023,” published on December 18, the publication highlighted the firm’s successful effort to thwart generic challenges to two patents protecting Novo Nordisk’s blockbuster …
Eric Stone Speaks at 12th Annual Waseda-Penn Patent Law Conference
Partner Eric Alan Stone discussed patent litigation in America at the 12th annual Waseda-Penn Patent Law Conference in Tokyo, Japan on Dec. 1, 2023. Speaking alongside fellow panelists The Honorable Christopher Burke, United States Magistrate Judge in the District of Delaware, The Honorable Takafumi Kokubu, Presiding Judge of the Tokyo District Court, The Honorable Ryuichi …
Jennifer Wu Speaks on Panel About BPCIA Litigation
December 6, 2023 — Founding Partner Jennifer Wu moderated an in-house counsel panel on current issues in Biologics Price Competition and Innovation (BPCIA) litigation on December 1, 2023 as part of the Practicing Law Institute’s Developments in Pharmaceutical and Biotech Patent Law 2023 program. The panelists Ryan Daniel (Fresenius), Petra Scamborova (Regeneron), Jill Schmidt (Genentech), …
Nick Groombridge and Steve Baughman Recognized as IAM Global Leaders
December 1, 2023—We are pleased to announce that founding partners Nick Groombridge and Steve Baughman were recognized in IAM’s 2024 Global Leaders Guide, which identifies leading practitioners in the patent field. Nick Groombridge is one of the nation’s leading trial lawyers, focusing exclusively on intellectual property litigation. Over the past 35 years, Nick has served …
Maxwell “Mac” Fox Moderates IAM IPBC Asia Panel on Patent Litigation and PTAB Developments
Tokyo-based partner Maxwell “Mac” Fox moderated a panel at IAM IPBC Asia on recent patent litigation and PTAB developments in the United States on November 30, 2023. The event brought together the region’s most senior thought-leaders and decision makers involved in global IP issues. The panelists discussed recent developments in patent litigation at the U.S. …
Founding Partners Nick Groombridge and Jennifer Wu Discuss Starting an Elite IP Firm Away from “Big Law” with Managing IP
Managing IP featured founding partners Nick Groombridge and Jennifer Wu in an article Finding a voice: IP boutique partners reflect on quitting ‘big law’. Nick and Jennifer spoke about the challenges of starting Groombridge, Wu, Baughman & Stone, working at their own IP boutique and their hopes for their first year. Nick talked about his desire to …
NAPABA Honors Jennifer Wu’s “Distinguished” Pro Bono Work at 35th Anniversary Gala
Founding partner Jennifer Wu was honored by the National Asian Pacific American Bar Association (NAPABA) with the 2023 Pro Bono Award at its anniversary gala on November 11. The annual award recognizes an attorney or a team of attorneys for outstanding achievements in pro bono service that involved impact litigation to advance or protect civil rights …
Five Partners Recognized by Benchmark Litigation as “Litigation Stars” and “Future Stars”
October 5, 2023 —We are pleased to announce that partners Nick Groombridge, Steven Baughman and Eric Stone have been recognized as “Litigation Stars” in the 2024 edition of Benchmark Litigation. Jennifer Wu and Megan F. Raymond have been recognized as “Future Stars” in the same edition. Nick Groombridge is one of the nation’s leading trial …
Firm Secures Significant PTAB Win for Novo Nordisk’s Blockbuster Diabetes and Obesity Treatment Drug
October 2, 2023 – Groombridge, Wu, Baughman & Stone successfully defended Novo Nordisk before the Patent Trial and Appeal Board against Mylan Pharmaceuticals in inter partes review (IPR) proceedings seeking to invalidate two Novo patents relating to its blockbuster semaglutide family of drugs, including Ozempic®, Wegovy®, and Rybelsus® (U.S. Patents Nos. 8,536,122 and 8,129,343). The …
Firm Wins a Major Victory on Behalf of Genentech
Groombridge, Wu, Baughman & Stone LLP won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough Hemophilia A treatment, HEMLIBRA® (emicizumab-kxwh), which has transformed the lives of thousands of patients. The U.S. District Court for the District of Delaware …